ReviewCureus2024
Efficacy of Acetazolamide for Treatment of Iatrogenic, Traumatic, and Spontaneous Cerebrospinal Fluid Leaks of the Anterior Skull Base: A Systematic Review.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use.Journal of neurological surgery. Part B, Skull base · 2026Article
- Spontaneous Middle Cranial Fossa Cerebrospinal Fluid Leaks and Intracranial Hypertension: Systematic Review With Meta-Analysis.Laryngoscope investigative otolaryngology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A cerebral spinal fluid (CSF) leak from the anterior skull base is a challenging neurosurgical issue that requires prompt recognition and treatment. Options for treatment include medical and surgical repair. A systematic review was performed screening for both retrospective and prospective clinical studies evaluating the efficacy of acetazolamide in the event of CSF leaks of the anterior skull base. We initially screened a total of 149 studies for inclusion, and 25 of them met the inclusion criteria. We included four studies on iatrogenic CSF leaks caused by surgery of the anterior cranial fossa, three studies on traumatic CSF leaks, and 18 studies on spontaneous CSF leaks caused by idiopathic intracranial hypertension (IIH). In the event of an iatrogenic CSF leak, 68 patients had undergone an endoscopic endonasal approach. CSF diversion and high-volume lumbar puncture were used frequently with adjunct acetazolamide administration. In the event of trauma, 187 patients were evaluated across the three included studies. Acetazolamide treatment was used as a single approach and effectively controlled CSF leaks. For spontaneous CSF leaks, acetazolamide is frequently used to increase the efficacy of surgical repair. Of the 431 patients, 327 received temporary CSF diversion in addition to acetazolamide. Surgical repair was the primary treatment in 277 patients. Acetazolamide should be considered as a treatment option in patients with CSF leak secondary to surgery of the anterior cranial fossa, trauma, and idiopathic causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.